Good luck to you, but PLEASE, if you don't own any AMBS, post your success on the CYCC board, not here. You do have me looking at CYCC though. Maybe a prelude to what could happen to AMBS in the future.
Cindy is correct in her assessment of DMND not participating in the market rally. She is wrong in that DMND rallied from the mid-teens and trounced the market in the process. I don't see DMND beaking down. Seems the only way to get rid of her once and for all is DMND to be acquired at a substantial premium. Until then, no matter what response we have, she will not go away!
Sweden's Tobii Technology, which has been developing eye-tracking technologies for over a decade, is incorporating its Tobii Gaze interface in a prototype of a new Ultrabook laptop PC, in partnership with touchpad and user interface tech firm Synaptics (SYNA). Users will be able to select apps and emails, surf the Web and perform other tasks hands-free, with eye gaze used to point and direct.
Remember the movie Poltergeist? Instead of "they're back" now we can say "it's back". What a pathetic life it has.
Yes, it draws ever-closer to $14 (while hitting a new high). Volume heavier than normal today (Wednesday 9/11), but not extremely so. The Seeking Alpha (SA) author keeps re-hashing the CWCO abnd ERII story. I doubt SA is enough to move either one significantly, but I love the potential with these small caps!
But not with water (Saudi Arabia): "Energy Recovery Joins Acciona on Saudi Desalination Works", We all know water is as precious as oil. Nice news for ERII, too bad it retreated from yesterday's gain, despite this news.
Nothing is obviously wrong. Added to my postion based upon this morning'sweakness (relative to other tech. stocks and the market) as well as the PR on meeting Windows 8.1 standards. Hang in there, it seems to have firmed up this afternoon.
Hyped before the start of a trade show then the plug is pulled. What type of excitement will be generated in Helsinki? Deja vu from the last time this was pumped and deflated. If MANF is so good, a larger pharma company should just buy them out!!! Dominion Capital are vultures. What a sweet deal they are getting; diluting the existing shareholders into oblivion. Raving and ranting because I have been sucked in before. This time I stood pat, although greed and temptation almost got more into more at $.08. Thank goodness my common sense prevailed.